Evidence map›Paper›PMID 25394679›Full record

ReviewCritical care (London, England)2014

Sepsis-associated hyperlactatemia.

Mercedes Garcia-Alvarez, Paul Marik, Rinaldo Bellomo

3 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Critical care (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 247 papers.

0numbers the graph read from it
0cells of the map it votes in
247citing papers in PubMed
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03078712 nacompletednot on this mapstarted 2017, after this paper: background citation

Early Goal Directed Therapy Using a Physiological Holistic View. A Multicenter Study in Latin America: The ANDROMEDA-SHOCK Study

TypeinterventionalSponsorPontificia Universidad Catolica de ChileRan2017 to 2018Enrolled424ConditionsSeptic Shock, Hyperlactatemia, Peripheral PerfusionArmsPeripheral Perfusion guided resuscitation, Lactate guided resuscitation
NCT03762005 naunknown statusnot on this mapstarted 2018, after this paper: background citation

Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock: ANDROMEDA-SHOCK PHYSIOLOGY STUDY

TypeinterventionalSponsorPontificia Universidad Catolica de ChileRan2018 to 2019Enrolled46ConditionsSeptic Shock, Hyperlactatemia, Peripheral PerfusionArmsCRT guided resuscitation, Lactate guided resuscitation
NCT07033910 completednot on this mapstarted 2023, after this paper: background citation

The Effect of Extracorporeal Sepsis Adsorption Column Use on Plasma Syndecan-1 Level and Mortality in Sepsis Patients

TypeobservationalSponsorOral MENTEŞRan2023 to 2024Enrolled91ConditionsSepsis, Syndecan 1, Extracorporeal Sepsis Adsorption ColumnArmssepsis adsorption column
3 · Its place in the literature

Who cites it

247 citing papers in PubMed, 474 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Hour-1 Sepsis Bundle: Updated Evidence.Journal of clinical medicine · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

187 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Mercedes Garcia-AlvarezDepartment of Anaesthesiology, Hospital de Sant Pau, Carrer de Sant Quintí 89, Barcelona, 08026, Spain. merced.garcia@austin.org.au.
Paul MarikDivision of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, VA, 23501, USA. marikpe@evms.edu.
Rinaldo BellomoDepartment of Intensive Care Medicine, Austin Hospital, Melbourne, Victoria, 3084, Australia. rinaldo.bellomo@austin.org.au.
Austin Hospital · AUAustralian and New Zealand Intensive Care Society · AUEastern Virginia Medical School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is overwhelming evidence that sepsis and septic shock are associated with hyperlactatemia (sepsis-associated hyperlactatemia (SAHL)). SAHL is a strong independent predictor of mortality and its presence and progression are widely appreciated by clinicians to define a very high-risk population. Until recently, the dominant paradigm has been that SAHL is a marker of tissue hypoxia. Accordingly, SAHL has been interpreted to indicate the presence of an 'oxygen debt' or 'hypoperfusion', which leads to increased lactate generation via anaerobic glycolysis. In light of such interpretation of the meaning of SAHL, maneuvers to increase oxygen delivery have been proposed as its treatment. Moreover, lactate levels have been proposed as a method to evaluate the adequacy of resuscitation and the nature of the response to the initial treatment for sepsis. However, a large body of evidence has accumulated that strongly challenges such notions. Much evidence now supports the view that SAHL is not due only to tissue hypoxia or anaerobic glycolysis. Experimental and human studies all consistently support the view that SAHL is more logically explained by increased aerobic glycolysis secondary to activation of the stress response (adrenergic stimulation). More importantly, new evidence suggests that SAHL may actually serve to facilitate bioenergetic efficiency through an increase in lactate oxidation. In this sense, the characteristics of lactate production best fit the notion of an adaptive survival response that grows in intensity as disease severity increases. Clinicians need to be aware of these developments in our understanding of SAHL in order to approach patient management according to biological principles and to interpret lactate concentrations during sepsis resuscitation according to current best knowledge.

Indexed as

AnimalsCell HypoxiaHumansHyperlactatemiaLactic AcidOxygen ConsumptionSepsisLactic Acid

Identifiers

PMID25394679
PMCPMC4421917
OpenAlexW2152154097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.